TAVR as WP said is a game changer but it is a long road ahead, many bridges to cross before we even dream of fda approval.
First let’s get the ip’s registered that will be a big step, that’s when we will see a deal done and I expect it will be a BIG deal. Then with a partner they can start looking at trials and work toward fda approval.
I have no knowledge of the process but I’m assuming it will be a little less complicated given tavr is now an excepts procedure and we have fda approval for for our patches.
Ann: Appendix 4C - quarterly, page-77
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $342.3M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $46.99K | 2.617K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 116 | $17.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.00 | 83 | 2 |
View Market Depth
| Last trade - 14.26pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |